Miracll Chemicals Co.,Ltd

SZSE:300848.SZ

20.48 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 413.136385.857358.32397.794401.371317.66308.822372.843402.302391.095394.36377.355253.011273.028248.641229.883163.202115.136199.459171.929168.586108.544148.015148.015147.788147.788145.045145.045118.143118.14398.19198.19169.06569.06557.1657.1652.70452.704
Cost of Revenue 363.975341.259325.123341.159341.706260.015263.262326.299343.103342.102323.93326.711213.841229.171190.349186.545125.90190.605145.889133.845123.6587.486119.834119.834120.512120.512118.833118.83396.50196.50180.77280.77253.84953.84945.41345.41343.62143.621
Gross Profit 49.1644.59833.19756.63659.66557.64545.5646.54459.248.99370.42950.64439.16943.85758.29243.33837.30124.53153.5738.08444.93721.05728.18128.18127.27527.27526.21226.21221.64121.64117.41917.41915.21515.21511.74711.7479.0839.083
Gross Profit Ratio 0.1190.1160.0930.1420.1490.1810.1480.1250.1470.1250.1790.1340.1550.1610.2340.1890.2290.2130.2690.2220.2670.1940.190.190.1850.1850.1810.1810.1830.1830.1770.1770.220.220.2060.2060.1720.172
Reseach & Development Expenses 20.14319.34519.35720.86517.19815.40418.43616.11418.69517.08420.02914.79410.13311.43512.9099.0676.3643.9137.126.6735.6144.3225.575.575.1295.1294.7694.7694.5354.53500002.0322.0322.0322.032
General & Administrative Expenses -0.158.507-9.70317.6480.147.772-7.05513.72-0.7887.895-7.38813.381-0.7275.081-5.3555.399-1.2992.973-12.0523.2113.1222.6143.1833.1832.7952.7952.8952.8951.6661.6664.8364.8365.1665.1663.9413.9412.9932.993
Selling & Marketing Expenses 5.1273.9976.7284.0133.4012.6245.2982.7283.5192.2574.4822.142.1492.6764.2072.126-1.4634.78.216.2515.9324.4454.7154.7154.4044.4045.25.23.3513.3514.0634.0632.9282.9282.3822.3821.851.85
SG&A 12.43412.504-2.97521.663.54110.396-1.75816.4482.73110.152-2.90615.5211.4227.758-1.1487.525-2.7627.672-3.8429.4629.0547.0588.1228.1227.1997.1998.0958.0955.0165.0168.8998.8998.0948.0945.9385.9385.2285.228
Other Expenses -1.7020.071-0.042-0.088-0.058-0.085-0.569-0.2370.079-0.058-0.4740.0060.0120.086-0.077-0.1240.871-0.268-2.112-0.046-1.1560.2010000000000000000
Operating Expenses 34.27926.95328.46134.34430.73227.29834.03621.6923.55626.78832.23220.53615.13119.816.28416.9316.71511.87721.27615.57813.77811.74713.69113.69112.43312.43313.00813.0089.339.339.3089.3087.4197.4195.3535.3535.3785.378
Operating Income 14.88214.3249.18520.48432.59827.76215.73430.16839.72126.44741.72735.59827.53926.40347.51125.82330.99711.87934.07122.26532.2398.22613.74513.74514.59214.59213.19213.19211.711.78.0448.0446.9186.9185.6535.6533.6863.686
Operating Income Ratio 0.0360.0370.0260.0510.0810.0870.0510.0810.0990.0680.1060.0940.1090.0970.1910.1120.190.1030.1710.130.1910.0760.0930.0930.0990.0990.0910.0910.0990.0990.0820.0820.10.10.0990.0990.070.07
Total Other Income Expenses Net 5.621-3.251-1.079-0.088-0.058-0.085-0.569-0.2370.079-0.058-0.4740.0060.0120.086-0.578-0.1240.959-0.268-0.08-0.046-1.1560.2011.7631.7630.250.250.0120.0120.7290.7290.0860.0860.8780.8780.7140.7140.0470.047
Income Before Tax 20.50214.3949.14320.39632.5427.67715.16529.93139.826.38941.25335.60427.55126.48846.93225.69831.95611.61133.99222.21931.0848.42715.50715.50714.84214.84213.20413.20412.42912.4298.1298.1297.7967.7966.3676.3673.7333.733
Income Before Tax Ratio 0.050.0370.0260.0510.0810.0870.0490.080.0990.0670.1050.0940.1090.0970.1890.1120.1960.1010.170.1290.1840.0780.1050.1050.10.10.0910.0910.1050.1050.0830.0830.1130.1130.1110.1110.0710.071
Income Tax Expense 2.5882.085-10.032.6615.0253.996-14.4034.4326.6493.779-1.9885.0844.4843.9933.7773.8584.791.7422.6483.3335.1181.2591.2571.2571.4061.4061.9811.9811.4471.4471.1451.1451.1691.1690.6780.6780.9480.948
Net Income 18.90712.32818.38318.24427.57123.66530.33325.38432.95922.60643.06230.52223.06822.49643.15521.84127.1669.8731.34418.88625.9667.16814.2514.2513.43713.43711.22311.22310.98210.9826.9846.9846.6276.6275.695.692.7852.785
Net Income Ratio 0.0460.0320.0510.0460.0690.0740.0980.0680.0820.0580.1090.0810.0910.0820.1740.0950.1660.0860.1570.110.1540.0660.0960.0960.0910.0910.0770.0770.0930.0930.0710.0710.0960.0960.10.10.0530.053
EPS 0.0460.040.060.0590.0920.0790.10.0850.110.0750.110.0780.0770.0760.150.080.120.0440.280.0840.0730.0310.140.140.130.140.110.110.110.110.0680.0680.0680.0680.0540.0540.050.05
EPS Diluted 0.0460.040.060.0590.0920.0790.10.0850.110.0730.110.0780.0770.0760.150.080.120.0440.280.0840.0730.0310.0640.140.130.140.110.110.110.110.0680.0680.0680.0680.0540.0540.050.05
EBITDA 24.40524.32710.48824.38337.31434.87620.79331.40542.19526.34446.32234.32828.30928.98645.68927.24134.51818.18431.24223.97733.78813.43718.98618.98614.66314.66315.41815.41813.40113.4019.3599.3597.9787.9786.5436.5434.4474.447
EBITDA Ratio 0.0590.0630.0290.0610.0930.110.0670.0840.1050.0670.1170.0910.1120.1060.1840.1180.2120.1580.1570.1390.20.1240.1280.1280.0990.0990.1060.1060.1130.1130.0950.0950.1160.1160.1140.1140.0840.084